Remission Status at Transplantation and Treatment History Determine the Survival Chances of Patients after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia Who Had Received Pre-Treatment with Idelalisib: A Report from the EBMT Chronic Malignancies Working Party

Johannes Schetelig;MD;Patrice Chevallier;MD;Michel Van Gelder;MD PhD;Jennifer Hoek;Olivier Hermine;Ronjon Chakraverty;BMBS PhD;Paul Browne;MD;Noel Milpied;Michele Malagola

Membro del Collaboration Group

;MD;Gerard Socie;MD PhD;Julio Delgado;MD;Eric Deconinck;MD PhD;Gandhi Damaj;MD;Catherine Cordonnier;MD;Dietrich W Beelen;MD PhD;Stephanie Nguyen;MD PhD;Emmanouil Nikolousis;Arne Brecht;MD;Jiri Mayer;Prof;MD SCs;Mathilde Hunault;MD PhD;Jörg Thomas Bittenbring;MD;Catherine Thieblemont;MD PhD;Stéphane Leprêtre;MD;Liesbeth C de Wreede;PhD;Peter Dreger;MD;Nicolaus Kröger

2017-01-01